SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Magainin Pharm (MAGN)
MAGN 9.090+6.2%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (215)10/29/1999 10:00:00 PM
From: Shlepper  Read Replies (1) of 233
 
Mike,

Very interesting post. I, too, have been attracted to biotechs and they comprise around 3/4 of my portfolio. But, like you, I have found success outside of biotechs - in LWIN most recently, and in AFLAC and Qualcomm long term. But the cheap biotechs don't have a great track record.

I had hoped that TCLN - with their science, could overcome their management, but that was not to be. I'm hopeful on PARS but some questions have arisen on that management. My successful biotech type stocks I bought over $5 or $10. One Medimmune makes up for several losers. With everything I've seen and learned over the years, my instincts tell me that Magainin will be one of the eventul big winners. My problem is that I have only 1 year left before I need to pay for 2 overlapping kids in college, so I may need to start tapping some of my long term holds.

Best of Luck - Hope you catch the hot stock (please let it be Magainin!).

Shep
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext